PACIOTTI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 638
EU - Europa 494
AS - Asia 239
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.374
Nazione #
US - Stati Uniti d'America 637
IT - Italia 114
SG - Singapore 105
IE - Irlanda 101
SE - Svezia 100
CN - Cina 82
UA - Ucraina 39
DE - Germania 33
TR - Turchia 31
GB - Regno Unito 27
FR - Francia 20
RU - Federazione Russa 17
IN - India 14
CZ - Repubblica Ceca 12
FI - Finlandia 12
BE - Belgio 7
AT - Austria 4
VN - Vietnam 4
PL - Polonia 3
BR - Brasile 2
ES - Italia 2
HK - Hong Kong 2
CA - Canada 1
EU - Europa 1
KR - Corea 1
LT - Lituania 1
NL - Olanda 1
PT - Portogallo 1
Totale 1.374
Città #
Chandler 137
Dublin 101
Singapore 93
Jacksonville 71
Chieti 40
Princeton 40
Ashburn 36
Ann Arbor 27
Dearborn 26
Southend 24
Santa Clara 21
Beijing 19
Izmir 19
Wilmington 19
Altamura 18
Brno 12
Nanjing 11
Boardman 9
Cambridge 9
Nanchang 9
Washington 9
Falls Church 8
Brussels 7
Dallas 7
Hebei 7
Los Angeles 7
Milan 6
Munich 6
Hangzhou 5
Seattle 5
Carbondale 4
Dong Ket 4
Jiaxing 4
Norwalk 4
Rome 4
Vienna 4
Changsha 3
Helsinki 3
Kraków 3
Lappeenranta 3
Redwood City 3
Rende 3
Tianjin 3
Woodbridge 3
Atlanta 2
Bosa 2
Campinas 2
Fort Worth 2
Guangzhou 2
Hong Kong 2
Jinan 2
Molfetta 2
Perugia 2
Romola 2
Shenyang 2
Amsterdam 1
Andover 1
Ascoli Piceno 1
Avezzano 1
Bangalore 1
Bellante 1
Campobasso 1
Changchun 1
Chicago 1
Cianciana 1
Florence 1
Frankfurt am Main 1
Fuzhou 1
Grevenbroich 1
Hanover 1
Hefei 1
Houston 1
Huilong 1
Huzhou 1
Kunming 1
Lanzhou 1
Miami 1
Montesilvano Marina 1
Mountain View 1
Naples 1
Ningbo 1
Nürnberg 1
Orange 1
Orsogna 1
Pescara 1
Porto 1
Quzhou 1
Recanati 1
San Vito Chietino 1
Sanremo 1
Shanghai 1
Spoltore 1
Taizhou 1
Tappahannock 1
Toronto 1
Totale 918
Nome #
Recent developments of amidine-like compounds as selective NOS inhibitors 121
Effects of Geranyloxycinnamic Acids on COX-2 and iNOS Functionalities in LPS-Stimulated U937 Mononuclear Cells 107
Binding motifs of cisplatin interaction with simple biomolecules and aminoacid targets probed by IR ion spectroscopy 93
Serine O-sulfation probed by IRMPD spectroscopy 86
Investigation of the molecular similarity in closely related protein systems: The PrP case study 83
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 82
Studies on the interaction of 4 '-geranyloxyferulic acid and nelumal A with pro-inflammatory enzymes 77
null 77
null 73
An insight of early PrP-E200K aggregation by combined molecular dynamics/fragment molecular orbital approaches 72
Cisplatin and transplatin interaction with methionine: Bonding motifs assayed by vibrational spectroscopy in the isolated ionic complexes 71
Characterization of PD-L1 binding sites by a combined FMO/GRID-DRY approach 69
Short-lived intermediates (encounter complexes) in cisplatin ligand exchange elucidated by infrared ion spectroscopy 68
Computational Investigation of IR Spectra of Electrospray Ionized Biomolecules 67
Computational investigations of bioinorganic complexes: The case of calcium, gold and platinum ions 66
Multilayered Modelling of the Metallation of Biological Targets 47
Dual carbonic anhydrase ix/xii inhibitors and carbon monoxide releasing molecules modulate LPS-mediated inflammation in mouse macrophages 39
Hampering the early aggregation of PrP-E200K protein by charge-based inhibitors: a computational study 35
Reactions of cisplatin and cis-[PtI2(NH3)2] with molecular models of relevant protein sidechains: A comparative analysis 32
IRMPD Spectroscopy of Bare Monodeprotonated Genistein, an Antioxidant Flavonoid 30
From Preassociation to Chelation: A Survey of Cisplatin Interaction with Methionine at Molecular Level by IR Ion Spectroscopy and Computations 27
Homodimeric complexes of the 90-231 human prion: a multilayered computational study based on FMO/GRID-DRY approach 23
MD-DFT Computational Studies on the Mechanistic and Conformational Parameters for the Chemoselective Tyrosine Residue Reactions of G-Protein-Coupled Receptor Peptides with [Cp*Rh(H2O)(3)](OTf)(2 )in Water To Form Their [(?(6)-Cp*Rh-Tyr(#))-GPCR peptide](2+) Complexes: Noncovalent H-Bonding Interactions, Molecular Orbital Analysis, Thermodynamics, and Lowest Energy Conformations 21
Elusive intermediates in cisplatin reaction with target amino acids: Platinum(II)-cysteine complexes assayed by IR ion spectroscopy and DFT calculations 19
Improving the accuracy of the FMO binding affinity prediction of ligand-receptor complexes containing metals 16
A computational insight on the aromatic amino acids conjugation with [Cp*Rh(H2O)3]2+ by using the meta-dynamics/FMO3 approach 16
The FMO2 analysis of the ligand-receptor binding energy: the Biscarbene-Gold(I)/DNA G-Quadruplex case study 14
A Comprehensive Computational Insight into the PD-L1 Binding to PD-1 and Small Molecules 8
Combining the Fragment Molecular Orbital and GRID Approaches for the Prediction of Ligand–Metalloenzyme Binding Affinity: The Case Study of hCA II Inhibitors 6
Vibrational analysis of auranofin complexes with cysteine and selenocysteine unveils distinct binding motifs and specific unimolecular reactivity 5
IRMPD spectroscopy and quantum-chemical simulations of the reaction products of cisplatin with the dipeptide CysGly 4
Insights on the activity of platinum-based anticancer complexes through computational methods 4
Structure and dynamics of gas phase ions: Interplay between experiments and computations in IRMPD spectroscopy 3
Carbon Monoxide Release from Aryl-Propargyl Dicobalt(0)Hexacarbonyl Derivatives: A Computational and Experimental Study 2
Totale 1.563
Categoria #
all - tutte 7.065
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.065


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020166 0 0 0 0 22 20 24 12 13 40 29 6
2020/2021124 13 0 19 14 1 26 9 10 13 7 4 8
2021/2022145 11 7 3 28 10 6 5 7 7 6 13 42
2022/2023386 31 78 23 41 21 72 17 28 49 7 12 7
2023/2024217 10 12 18 5 22 58 27 28 1 11 6 19
2024/2025227 35 100 64 11 17 0 0 0 0 0 0 0
Totale 1.563